Abstract
Measurement of the serum thyroglobulin level may be more sensitive than total-body scan using sodium iodide 131 for detecting recurrences from well-differentiated thyroid cancer. We have evaluated the merit of these two methods through a retrospective chart review of patients followed up at the Milton S. Hershey Medical Center, Hershey, Pa. We found that in 17 (45%) of 38 follow-up visits, the presence of interfering antibodies prevented the measurement of serum thyroglobulin levels. Furthermore, such determination was less sensitive than iodine 131 total-body scan in detecting residual thyroid tissue and/or cancer in the neck area. We concluded that iodine 131 total-body scan is the preferable method of follow-up, particularly when the oral of therapy is complete ablation of thyroid tissue.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 437-439 |
| Number of pages | 3 |
| Journal | Archives of Internal Medicine |
| Volume | 150 |
| Issue number | 2 |
| State | Published - Feb 1990 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- Internal Medicine
Fingerprint
Dive into the research topics of 'Thyroglobulin measurement vs iodine 131 total-body scan for follow-up of well-differentiated thyroid cancer'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver